Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06355401
PHASE2/PHASE3
Maintenance Hormonal Therapy and DLBCL
Sponsor: Sohag University
View on ClinicalTrials.gov
Summary
the study aims to detect the benefit of maintenance tamoxifen after achieving CR with conventional immuno-chemotherapy and/or radiotherapy in patients with DLDCL
Official title: Effect of Maintenance Hormonal Therapy on the Outcome of Patients With DLBCL
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-04
Completion Date
2029-03
Last Updated
2024-04-09
Healthy Volunteers
No
Conditions
Interventions
DRUG
Tamoxifen 20mg
maintenance TAM 20 mg daily for DLBCL who achieve CR after chemotherapy and/or radiotherapy and/or BMT